Flotufolastat F-18 Gallium
Small Molecule
Overview
Flotufolastat F-18 Gallium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL5314559).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Flotufolastat F-18 Gallium expires 27 Nov 2041 and exclusivity 25 May 2028. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.